High frequency of new recombinant forms in HIV-1 transmission networks demonstrated by full genome sequencing.


Journal

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
ISSN: 1567-7257
Titre abrégé: Infect Genet Evol
Pays: Netherlands
ID NLM: 101084138

Informations de publication

Date de publication:
10 2020
Historique:
received: 28 02 2020
revised: 08 05 2020
accepted: 12 05 2020
pubmed: 18 5 2020
medline: 11 8 2021
entrez: 18 5 2020
Statut: ppublish

Résumé

The HIV-1 epidemic in Belgium is primarily driven by MSM. In this patient population subtype B predominates but an increasing presence of non-B subtypes has been reported. We aimed to define to what extent the increasing subtype heterogeneity in a high at risk population induces the formation and spread of new recombinant forms. The study focused on transmission networks that reflect the local transmission to an important extent. One hundred and five HIV-1 transmission clusters were identified after phylogenetic analysis of 2849 HIV-1 pol sequences generated for the purpose of baseline drug resistance testing between 2013 and 2017. Of these 105 clusters, 62 extended in size during the last two years and were therefore considered as representing ongoing transmission. These 62 clusters included 774 patients in total. From each cluster between 1 and 3 representative patients were selected for near full-length viral genome sequencing. In total, the full genome sequence of 101 patients was generated. Indications for the presence of a new recombinant form were found for 10 clusters. These 10 clusters represented 105 patients or 13.6% of the patients covered by the study. The findings clearly show that new recombinant strains highly contribute to local transmission, even in an epidemic that is largely MSM and subtype B driven. This is an evolution that needs to be monitored as reshuffling of genome fragments through recombination may influence the transmissibility of the virus and the pathology of the infection. In addition, important changes in the sequence of the viral genome may challenge the performance of tests used for diagnosis, patient monitoring and drug resistance analysis.

Identifiants

pubmed: 32417307
pii: S1567-1348(20)30196-9
doi: 10.1016/j.meegid.2020.104365
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104365

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Laura Hebberecht (L)

Aids Reference Laboratory, Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.

Virginie Mortier (V)

Aids Reference Laboratory, Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.

Kenny Dauwe (K)

Aids Reference Laboratory, Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.

Marlies Schauvliege (M)

Aids Reference Laboratory, Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.

Delfien Staelens (D)

Aids Reference Laboratory, Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.

Els Demecheleer (E)

Aids Reference Laboratory, Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.

Karolien Stoffels (K)

Aids Reference Laboratory, Centre Hospitalier Universitaire St. Pierre, Brussels, Belgium.

Fien Vanroye (F)

HIV/STD Reference Laboratory, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Marie-Luce Delforge (ML)

Aids Reference Laboratory, Université Libre de Bruxelles, Brussels, Belgium.

Ellen Vancutsem (E)

Aids Reference Laboratory, Vrije Universiteit Brussel, Brussels, Belgium.

Géraldine Dessilly (G)

Aids Reference Laboratory, Medical Microbiology Unit, Université Catholique de Louvain, Brussels, Belgium.

Dolorès Vaira (D)

Aids Reference Laboratory, Centre Hospitalier Universitaire de Liège, Liège, Belgium.

Kristel Van Laethem (K)

Aids Reference Laboratory, University Hospital Leuven, Leuven, Belgium; Rega Institute for Medical Research, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.

Chris Verhofstede (C)

Aids Reference Laboratory, Department of Diagnostic Sciences, Ghent University, Ghent, Belgium. Electronic address: chris.verhofstede@ugent.be.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH